Cargando…
Immune monitoring in patients with colorectal cancer stage II
Autores principales: | Zavadova, Eva, Vocka, Michal, Spacek, Jan, Francis, Nicole, Konopasek, Bohuslav, Fucikova, Terezie, Skalova, Helena, Dundr, Pavel, Petruzelka, Lubos, Rau, Tilman T, Geppert, Carol, Hartmann, Arndt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649286/ http://dx.doi.org/10.1186/2051-1426-3-S2-P266 |
Ejemplares similares
-
Colorectal cancer patients show decrease in cellular immunity and enhanced plasma level of transforming growth factor – beta and vascular endothelial growth factor (VEGF)
por: Zavadova, Eva, et al.
Publicado: (2013) -
Apoptosis – associated genes and their role in predicting responses to neoadjuvant breast cancer treatment
por: Tvrdík, Daniel, et al.
Publicado: (2012) -
Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic
por: Zimovjanova, Martina, et al.
Publicado: (2023) -
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial
por: Bielcikova, Zuzana, et al.
Publicado: (2023) -
Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers
por: Vocka, Michal, et al.
Publicado: (2019)